全身麻酔薬の世界及び中国市場

• 英文タイトル：Global and China General Anesthesia Drugs Market Insights, Forecast to 2027

• レポートコード：QY2108PAL8838 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、142ページ • 納品方法：Eメール（納期：1日） • 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ
Enterprise License	￥1,154,400 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の当調査資料ではグローバルにおける全身麻酔薬の市場規模（2016年-2027年）と動向についてまとめました。中国市場については主要プレイヤーの市場シェア、全身麻酔薬の種類別市場規模（プロポフォール、エトミデート、ミダゾラム、セボフルラン、イソフルラン、その他）、用途別市場規模（静脈麻酔薬、吸入麻酔薬）も掲載しています。他に、北米・アメリカ市場、ヨーロッパ市場、アジア太平洋・日本市場、中南米市場、中東・アフリカ市場の市場規模、グローバル市場機会・課題・リスク要因、バリューチェーン・販売チャネル、主要プレイヤーの情報なども掲載しています。 ・調査の概要 ・調査のサマリー ・世界の全身麻酔薬市場動向 ・グローバル主要プレイヤーの競争状況・市場シェア ・世界における全身麻酔薬の種類別市場規模（2016年-2027年）：プロポフォール、エトミデート、ミダゾラム、セボフルラン、イソフルラン、その他 ・世界における全身麻酔薬の用途別市場規模（2016年-2027年）：静脈麻酔薬、吸入麻酔薬 ・全身麻酔薬の中国市場分析 - 全身麻酔薬の中国市場規模（2016年-2027年） - 中国における全身麻酔薬の主要プレイヤー別市場シェア - 中国における全身麻酔薬の種類別市場規模：プロポフォール、エトミデート、ミダゾラム、セボフルラン、イソフルラン、その他 - 中国における全身麻酔薬の用途別市場規模：静脈麻酔薬、吸入麻酔薬 ・全身麻酔薬の北米市場（2016年-2027年） ・全身麻酔薬のヨーロッパ市場（2016年-2027年） ・全身麻酔薬のアジア太平洋市場（2016年-2027年） ・全身麻酔薬の中南米市場（2016年-2027年） ・全身麻酔薬の中東・アフリカ市場（2016年-2027年） ・主要プレイヤーの情報：Astrazeneca、Fresenius-Kabi、AbbVie、Baxter Healthcare、B.Braun、Maruishi、Piramal、Hikma Pharmaceuticals、Mylan、Nhwa、Hengrui、Lunan ・市場機会・課題・リスク要因分析 ・バリューチェーン・販売チャネル分析 ・...

General anesthetics are drugs that have the ability to bring about a reversible loss of consciousness. Anesthetists administer these drugs to induce or maintain general anaesthesia to facilitate surgery. Some of these drugs are also used in lower dosages for pain management.
The major players in global General Anesthesia Drugs market include Astrazeneca, Fresenius-Kabi, B.Braun, etc. The top 3 players occupy about 40% shares of the global market. North America and Europe are main markets, they occupy about 60% of the global market. Propofol is the main type, with a share about 30%. Intravenous Anesthetics is the main application, which holds a share about 70%.

Market Analysis and Insights: Global and China General Anesthesia Drugs Market
This report focuses on global and China General Anesthesia Drugs market.
In 2020, the global General Anesthesia Drugs market size was US$ 7291 million and it is expected to reach US$ 8829.4 million by the end of 2027, with a CAGR of 2.7% during 2021-2027. In China the General Anesthesia Drugs market size is expected to grow from US$ XX million in 2020 to US$ XX million by 2027, at a CAGR of XX% during the forecast period.

Global General Anesthesia Drugs Scope and Market Size
General Anesthesia Drugs market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global General Anesthesia Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027.
For China market, this report focuses on the General Anesthesia Drugs market size by players, by Type, and by Application, for the period 2016-2027. The key players include the global and local players which play important roles in China.

Segment by Type
Propofol
Etomidate
Midazolam
Sevoflurane
Isoflurane
Others

Segment by Application
Intravenous Anesthetics
Inhalational Anesthetics

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

By Company
Astrazeneca
Fresenius-Kabi
AbbVie
Baxter Healthcare
B.Braun
Maruishi
Piramal
Hikma Pharmaceuticals
Mylan
Nhwa
Hengrui
Lunan

レポート目次

---

1 Study Coverage
1.1 General Anesthesia Drugs Product Introduction
1.2 Market by Type
1.2.1 Global General Anesthesia Drugs Market Size Growth Rate by Type
1.2.2 Propofol
1.2.3 Etomidate
1.2.4 Midazolam
1.2.5 Sevoflurane
1.2.6 Isoflurane
1.2.7 Others
1.3 Market by Application
1.3.1 Global General Anesthesia Drugs Market Size Growth Rate by Application
1.3.2 Intravenous Anesthetics
1.3.3 Inhalational Anesthetics
1.4 Study Objectives
1.5 Years Considered

2 Executive Summary
2.1 Global General Anesthesia Drugs Market Size, Estimates and Forecasts
2.1.1 Global General Anesthesia Drugs Revenue 2016-2027
2.1.2 Global General Anesthesia Drugs Sales 2016-2027
2.2 Global General Anesthesia Drugs, Market Size by Region: 2016 VS 2021 VS 2027
2.3 General Anesthesia Drugs Historical Market Size by Region (2016-2021)
2.3.1 Global General Anesthesia Drugs Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global General Anesthesia Drugs Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 General Anesthesia Drugs Market Estimates and Projections by Region (2022-2027)
2.4.1 Global General Anesthesia Drugs Sales Forecast by Region (2022-2027)
2.4.2 Global General Anesthesia Drugs Revenue Forecast by Region (2022-2027)

3 Global General Anesthesia Drugs Competitor Landscape by Players
3.1 Global Top General Anesthesia Drugs Manufacturers by Sales
3.1.1 Global General Anesthesia Drugs Sales by Manufacturer (2016-2021)
3.1.2 Global General Anesthesia Drugs Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top General Anesthesia Drugs Manufacturers by Revenue
3.2.1 Key General Anesthesia Drugs Manufacturers Covered: Ranking by Revenue
3.2.2 Global General Anesthesia Drugs Revenue by Manufacturers (2016-2021)
3.2.3 Global General Anesthesia Drugs Revenue Share by Manufacturers (2016-2021)
3.2.4 Global General Anesthesia Drugs Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by General Anesthesia Drugs Revenue in 2020
3.2.6 Global General Anesthesia Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global General Anesthesia Drugs Price by Manufacturers
3.4 Global General Anesthesia Drugs Manufacturing Base Distribution, Product Types
3.4.1 General Anesthesia Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers General Anesthesia Drugs Product Type
3.4.3 Date of International Manufacturers Enter into General Anesthesia Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2016-2027)
4.1 Global General Anesthesia Drugs Market Size by Type (2016-2021)
4.1.1 Global General Anesthesia Drugs Sales by Type (2016-2021)
4.1.2 Global General Anesthesia Drugs Revenue by Type (2016-2021)
4.1.3 General Anesthesia Drugs Average Selling Price (ASP) by Type (2016-2021)
4.2 Global General Anesthesia Drugs Market Size Forecast by Type (2022-2027)
4.2.1 Global General Anesthesia Drugs Sales Forecast by Type (2022-2027)
4.2.2 Global General Anesthesia Drugs Revenue Forecast by Type (2022-2027)
4.2.3 General Anesthesia Drugs Average Selling Price (ASP) Forecast by Type (2022-2027)

5 Breakdown Data by Application (2016-2027)
5.1 Global General Anesthesia Drugs Market Size by Application (2016-2021)
5.1.1 Global General Anesthesia Drugs Sales by Application (2016-2021)
5.1.2 Global General Anesthesia Drugs Revenue by Application (2016-2021)
5.1.3 General Anesthesia Drugs Price by Application (2016-2021)
5.2 General Anesthesia Drugs Market Size Forecast by Application (2022-2027)
5.2.1 Global General Anesthesia Drugs Sales Forecast by Application (2022-2027)
5.2.2 Global General Anesthesia Drugs Revenue Forecast by Application (2022-2027)
5.2.3 Global General Anesthesia Drugs Price Forecast by Application (2022-2027)

6 China by Players, Type and Application
6.1 China General Anesthesia Drugs Market Size YoY Growth 2016-2027
6.1.1 China General Anesthesia Drugs Sales YoY Growth 2016-2027
6.1.2 China General Anesthesia Drugs Revenue YoY Growth 2016-2027
6.1.3 China General Anesthesia Drugs Market Share in Global Market 2016-2027
6.2 China General Anesthesia Drugs Market Size by Players (International and Local Players)
6.2.1 China Top General Anesthesia Drugs Players by Sales (2016-2021)
6.2.2 China Top General Anesthesia Drugs Players by Revenue (2016-2021)
6.3 China General Anesthesia Drugs Historic Market Review by Type (2016-2021)
6.3.1 China General Anesthesia Drugs Sales Market Share by Type (2016-2021)
6.3.2 China General Anesthesia Drugs Revenue Market Share by Type (2016-2021)
6.3.3 China General Anesthesia Drugs Price by Type (2016-2021)
6.4 China General Anesthesia Drugs Market Estimates and Forecasts by Type (2022-2027)
6.4.1 China General Anesthesia Drugs Sales Forecast by Type (2022-2027)
6.4.2 China General Anesthesia Drugs Revenue Forecast by Type (2022-2027)
6.4.3 China General Anesthesia Drugs Price Forecast by Type (2022-2027)
6.5 China General Anesthesia Drugs Historic Market Review by Application (2016-2021)
6.5.1 China General Anesthesia Drugs Sales Market Share by Application (2016-2021)
6.5.2 China General Anesthesia Drugs Revenue Market Share by Application (2016-2021)
6.5.3 China General Anesthesia Drugs Price by Application (2016-2021)
6.6 China General Anesthesia Drugs Market Estimates and Forecasts by Application (2022-2027)
6.6.1 China General Anesthesia Drugs Sales Forecast by Application (2022-2027)
6.6.2 China General Anesthesia Drugs Revenue Forecast by Application (2022-2027)
6.6.3 China General Anesthesia Drugs Price Forecast by Application (2022-2027)

7 North America
7.1 North America General Anesthesia Drugs Market Size YoY Growth 2016-2027
7.2 North America General Anesthesia Drugs Market Facts & Figures by Country
7.2.1 North America General Anesthesia Drugs Sales by Country (2016-2021)
7.2.2 North America General Anesthesia Drugs Revenue by Country (2016-2021)
7.2.3 U.S.
7.2.4 Canada

8 Asia Pacific
8.1 Asia Pacific General Anesthesia Drugs Market Size YoY Growth 2016-2027
8.2 Asia Pacific General Anesthesia Drugs Market Facts & Figures by Region
8.2.1 Asia Pacific General Anesthesia Drugs Sales by Region (2016-2021)
8.2.2 Asia Pacific General Anesthesia Drugs Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia

9 Europe
9.1 Europe General Anesthesia Drugs Market Size YoY Growth 2016-2027
9.2 Europe General Anesthesia Drugs Market Facts & Figures by Country
9.2.1 Europe General Anesthesia Drugs Sales by Country (2016-2021)
9.2.2 Europe General Anesthesia Drugs Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy

10 Latin America
10.1 Latin America General Anesthesia Drugs Market Size YoY Growth 2016-2027
10.2 Latin America General Anesthesia Drugs Market Facts & Figures by Country
10.2.1 Latin America General Anesthesia Drugs Sales by Country (2016-2021)
10.2.2 Latin America General Anesthesia Drugs Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina

11 Middle East and Africa
11.1 Middle East and Africa General Anesthesia Drugs Market Size YoY Growth 2016-2027
11.2 Middle East and Africa General Anesthesia Drugs Market Facts & Figures by Country
11.2.1 Middle East and Africa General Anesthesia Drugs Sales by Country (2016-2021)
11.2.2 Middle East and Africa General Anesthesia Drugs Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 UAE

12 Company Profiles
12.1 Astrazeneca
12.1.1 Astrazeneca Corporation Information
12.1.2 Astrazeneca Description and Business Overview
12.1.3 Astrazeneca General Anesthesia Drugs Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Astrazeneca General Anesthesia Drugs Products Offered
12.1.5 Astrazeneca Recent Development
12.2 Fresenius-Kabi
12.2.1 Fresenius-Kabi Corporation Information
12.2.2 Fresenius-Kabi Description and Business Overview
12.2.3 Fresenius-Kabi General Anesthesia Drugs Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Fresenius-Kabi General Anesthesia Drugs Products Offered
12.2.5 Fresenius-Kabi Recent Development
12.3 AbbVie
12.3.1 AbbVie Corporation Information
12.3.2 AbbVie Description and Business Overview
12.3.3 AbbVie General Anesthesia Drugs Sales, Revenue and Gross Margin (2016-2021)
12.3.4 AbbVie General Anesthesia Drugs Products Offered
12.3.5 AbbVie Recent Development
12.4 Baxter Healthcare
12.4.1 Baxter Healthcare Corporation Information
12.4.2 Baxter Healthcare Description and Business Overview
12.4.3 Baxter Healthcare General Anesthesia Drugs Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Baxter Healthcare General Anesthesia Drugs Products Offered
12.4.5 Baxter Healthcare Recent Development
12.5 B.Braun
12.5.1 B.Braun Corporation Information
12.5.2 B.Braun Description and Business Overview
12.5.3 B.Braun General Anesthesia Drugs Sales, Revenue and Gross Margin (2016-2021)
12.5.4 B.Braun General Anesthesia Drugs Products Offered
12.5.5 B.Braun Recent Development
12.6 Maruishi
12.6.1 Maruishi Corporation Information
12.6.2 Maruishi Description and Business Overview
12.6.3 Maruishi General Anesthesia Drugs Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Maruishi General Anesthesia Drugs Products Offered
12.6.5 Maruishi Recent Development
12.7 Piramal
12.7.1 Piramal Corporation Information
12.7.2 Piramal Description and Business Overview
12.7.3 Piramal General Anesthesia Drugs Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Piramal General Anesthesia Drugs Products Offered
12.7.5 Piramal Recent Development
12.8 Hikma Pharmaceuticals
12.8.1 Hikma Pharmaceuticals Corporation Information
12.8.2 Hikma Pharmaceuticals Description and Business Overview
12.8.3 Hikma Pharmaceuticals General Anesthesia Drugs Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Hikma Pharmaceuticals General Anesthesia Drugs Products Offered
12.8.5 Hikma Pharmaceuticals Recent Development
12.9 Mylan
12.9.1 Mylan Corporation Information
12.9.2 Mylan Description and Business Overview
12.9.3 Mylan General Anesthesia Drugs Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Mylan General Anesthesia Drugs Products Offered
12.9.5 Mylan Recent Development
12.10 Nhwa
12.10.1 Nhwa Corporation Information
12.10.2 Nhwa Description and Business Overview
12.10.3 Nhwa General Anesthesia Drugs Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Nhwa General Anesthesia Drugs Products Offered
12.10.5 Nhwa Recent Development
12.11 Astrazeneca
12.11.1 Astrazeneca Corporation Information
12.11.2 Astrazeneca Description and Business Overview
12.11.3 Astrazeneca General Anesthesia Drugs Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Astrazeneca General Anesthesia Drugs Products Offered
12.11.5 Astrazeneca Recent Development
12.12 Lunan
12.12.1 Lunan Corporation Information
12.12.2 Lunan Description and Business Overview
12.12.3 Lunan General Anesthesia Drugs Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Lunan Products Offered
12.12.5 Lunan Recent Development

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 General Anesthesia Drugs Industry Trends
13.2 General Anesthesia Drugs Market Drivers
13.3 General Anesthesia Drugs Market Challenges
13.4 General Anesthesia Drugs Market Restraints

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 General Anesthesia Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

List of Tables
Table 1. Global General Anesthesia Drugs Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Propofol
Table 3. Major Manufacturers of Etomidate
Table 4. Major Manufacturers of Midazolam
Table 5. Major Manufacturers of Sevoflurane
Table 6. Major Manufacturers of Isoflurane
Table 7. Major Manufacturers of Others
Table 8. Global General Anesthesia Drugs Market Size Growth Rate by Application (2021-2027) & (K L)
Table 9. Global General Anesthesia Drugs Market Size by Region (K L) & (US$ Million), 2016 VS 2021 VS 2027
Table 10. Global General Anesthesia Drugs Sales by Regions (2016-2021) & (K L)
Table 11. Global General Anesthesia Drugs Sales Market Share by Regions (2016-2021)
Table 12. Global General Anesthesia Drugs Revenue by Regions (2016-2021) & (US$ Million)
Table 13. Global General Anesthesia Drugs Sales Forecast by Region (2022-2027) & (K L)
Table 14. Global General Anesthesia Drugs Sales Market Share Forecast by Region (2022-2027)
Table 15. Global General Anesthesia Drugs Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 16. Global General Anesthesia Drugs Revenue Market Share Forecast by Region (2022-2027)
Table 17. Global General Anesthesia Drugs Sales by Manufacturers (2016-2021) (K L)
Table 18. Global General Anesthesia Drugs Sales Share by Manufacturers (2016-2021)
Table 19. Ranking of Global Top General Anesthesia Drugs Manufacturers by Revenue (US$ Million) in 2020
Table 20. General Anesthesia Drugs Revenue by Manufacturers (2016-2021) (US$ Million)
Table 21. General Anesthesia Drugs Revenue Share by Manufacturers (2016-2021)
Table 22. Global General Anesthesia Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
Table 23. Global General Anesthesia Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in General Anesthesia Drugs as of 2020)
Table 24. Key Manufacturers General Anesthesia Drugs Price (2016-2021) (US$/L)
Table 25. General Anesthesia Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table 26. Manufacturers General Anesthesia Drugs Product Type
Table 27. Date of International Manufacturers Enter into General Anesthesia Drugs Market
Table 28. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 29. Global General Anesthesia Drugs Sales by Type (2016-2021) (K L)
Table 30. Global General Anesthesia Drugs Sales Share by Type (2016-2021)
Table 31. Global General Anesthesia Drugs Revenue by Type (2016-2021) (US$ Million)
Table 32. Global General Anesthesia Drugs Revenue Share by Type (2016-2021)
Table 33. General Anesthesia Drugs Average Selling Price (ASP) by Type (2016-2021) & (US$/L)
Table 34. Global General Anesthesia Drugs Sales Forecast by Type (2022-2027) & (K L)
Table 35. Global General Anesthesia Drugs Sales Market Share Forecast by Type (2022-2027)
Table 36. Global General Anesthesia Drugs Revenue Forecast V (2022-2027) & (US$ Million)
Table 37. Global General Anesthesia Drugs Revenue Market Share Forecast by Type (2022-2027)
Table 38. Global General Anesthesia Drugs Average Selling Price (ASP) Forecast by Type (2022-2027) & (US$/L)
Table 39. Global General Anesthesia Drugs Sales by Application (2016-2021) (K L)
Table 40. Global General Anesthesia Drugs Sales Share by Application (2016-2021)
Table 41. Global General Anesthesia Drugs Revenue by Application (2016-2021) (US$ Million)
Table 42. Global General Anesthesia Drugs Revenue Share by Application (2016-2021)
Table 43. General Anesthesia Drugs Average Selling Price (ASP) by Application (2016-2021) & (US$/L)
Table 44. Global General Anesthesia Drugs Sales Forecast by Application (2022-2027) & (K L)
Table 45. Global General Anesthesia Drugs Sales Market Share Forecast by Application (2022-2027)
Table 46. Global General Anesthesia Drugs Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 47. Global General Anesthesia Drugs Revenue Market Share Forecast by Application (2022-2027)
Table 48. Global General Anesthesia Drugs Average Selling Price (ASP) Forecast by Application (2022-2027) & (US$/L)
Table 49. China General Anesthesia Drugs Sales (K L) of Key Companies (2016-2021)
Table 50. China General Anesthesia Drugs Sales Share by Company (2016-2021)
Table 51. China General Anesthesia Drugs Revenue (US$ Million) by Company (2016-2021)
Table 52. China General Anesthesia Drugs Revenue Share by Company (2016-2021)
Table 53. China General Anesthesia Drugs Sales (K L) by Type (2016-2021)
Table 54. China General Anesthesia Drugs Sales Share by Type (2016-2021)
Table 55. China General Anesthesia Drugs Revenue (US$ Million) Market Share by Type (2016-2021)
Table 56. China General Anesthesia Drugs Price (US$/L) by Type (2016-2021)
Table 57. China General Anesthesia Drugs Sales (K L) by Type (2022-2027)
Table 58. China General Anesthesia Drugs Sales Share by Type (2022-2027)
Table 59. China General Anesthesia Drugs Revenue (US$ Million) Market Share by Type (2022-2027)
Table 60. China General Anesthesia Drugs Revenue Share by Type (2022-2027)
Table 61. China General Anesthesia Drugs Price (US$/L) by Type (2022-2027)
Table 62. China General Anesthesia Drugs Sales (K L) by Application (2016-2021)
Table 63. China General Anesthesia Drugs Sales Share by Application (2016-2021)
Table 64. China General Anesthesia Drugs Revenue (US$ Million) Market Share by Application (2016-2021)
Table 65. China General Anesthesia Drugs Price (US$/L) by Application (2016-2021)
Table 66. China General Anesthesia Drugs Sales (K L) by Application (2022-2027)
Table 67. China General Anesthesia Drugs Sales Share by Application (2022-2027)
Table 68. China General Anesthesia Drugs Revenue (US$ Million) Market Share by Application (2022-2027)
Table 69. China General Anesthesia Drugs Revenue Share by Application (2022-2027)
Table 70. China General Anesthesia Drugs Price (US$/L) by Application (2022-2027)
Table 71. North America General Anesthesia Drugs Sales by Country (2016-2021) & (K L)
Table 72. North America General Anesthesia Drugs Sales Market Share by Country (2016-2021)
Table 73. North America General Anesthesia Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 74. North America General Anesthesia Drugs Revenue Market Share by Country (2016-2021)
Table 75. Asia Pacific General Anesthesia Drugs Sales by Region (2016-2021) & (K L)
Table 76. Asia Pacific General Anesthesia Drugs Sales Market Share by Region (2016-2021)
Table 77. Asia Pacific General Anesthesia Drugs Revenue by Region (2016-2021) & (US$ Million)
Table 78. Asia Pacific General Anesthesia Drugs Revenue Market Share by Region (2016-2021)
Table 79. Europe General Anesthesia Drugs Sales by Country (2016-2021) & (K L)
Table 80. Europe General Anesthesia Drugs Sales Market Share by Country (2016-2021)
Table 81. Europe General Anesthesia Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 82. Europe General Anesthesia Drugs Revenue Market Share by Country (2016-2021)
Table 83. Latin America General Anesthesia Drugs Sales by Country (2016-2021) & (K L)
Table 84. Latin America General Anesthesia Drugs Sales Market Share by Country (2016-2021)
Table 85. Latin Americaa General Anesthesia Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 86. Latin America General Anesthesia Drugs Revenue Market Share by Country (2016-2021)
Table 87. Middle East and Africa General Anesthesia Drugs Sales by Country (2016-2021) & (K L)
Table 88. Middle East and Africa General Anesthesia Drugs Sales Market Share by Country (2016-2021)
Table 89. Middle East and Africa General Anesthesia Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 90. Middle East and Africa General Anesthesia Drugs Revenue Market Share by Country (2016-2021)
Table 91. Astrazeneca Corporation Information
Table 92. Astrazeneca Description and Business Overview
Table 93. Astrazeneca General Anesthesia Drugs Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2016-2021)
Table 94. Astrazeneca General Anesthesia Drugs Product
Table 95. Astrazeneca Recent Development
Table 96. Fresenius-Kabi Corporation Information
Table 97. Fresenius-Kabi Description and Business Overview
Table 98. Fresenius-Kabi General Anesthesia Drugs Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2016-2021)
Table 99. Fresenius-Kabi Product
Table 100. Fresenius-Kabi Recent Development
Table 101. AbbVie Corporation Information
Table 102. AbbVie Description and Business Overview
Table 103. AbbVie General Anesthesia Drugs Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2016-2021)
Table 104. AbbVie Product
Table 105. AbbVie Recent Development
Table 106. Baxter Healthcare Corporation Information
Table 107. Baxter Healthcare Description and Business Overview
Table 108. Baxter Healthcare General Anesthesia Drugs Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2016-2021)
Table 109. Baxter Healthcare Product
Table 110. Baxter Healthcare Recent Development
Table 111. B.Braun Corporation Information
Table 112. B.Braun Description and Business Overview
Table 113. B.Braun General Anesthesia Drugs Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2016-2021)
Table 114. B.Braun Product
Table 115. B.Braun Recent Development
Table 116. Maruishi Corporation Information
Table 117. Maruishi Description and Business Overview
Table 118. Maruishi General Anesthesia Drugs Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2016-2021)
Table 119. Maruishi Product
Table 120. Maruishi Recent Development
Table 121. Piramal Corporation Information
Table 122. Piramal Description and Business Overview
Table 123. Piramal General Anesthesia Drugs Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2016-2021)
Table 124. Piramal Product
Table 125. Piramal Recent Development
Table 126. Hikma Pharmaceuticals Corporation Information
Table 127. Hikma Pharmaceuticals Description and Business Overview
Table 128. Hikma Pharmaceuticals General Anesthesia Drugs Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2016-2021)
Table 129. Hikma Pharmaceuticals Product
Table 130. Hikma Pharmaceuticals Recent Development
Table 131. Mylan Corporation Information
Table 132. Mylan Description and Business Overview
Table 133. Mylan General Anesthesia Drugs Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2016-2021)
Table 134. Mylan Product
Table 135. Mylan Recent Development
Table 136. Nhwa Corporation Information
Table 137. Nhwa Description and Business Overview
Table 138. Nhwa General Anesthesia Drugs Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2016-2021)
Table 139. Nhwa Product
Table 140. Nhwa Recent Development
Table 141. Hengrui Corporation Information
Table 142. Hengrui Description and Business Overview
Table 143. Hengrui General Anesthesia Drugs Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2016-2021)
Table 144. Hengrui Product
Table 145. Hengrui Recent Development
Table 146. Lunan Corporation Information
Table 147. Lunan Description and Business Overview
Table 148. Lunan General Anesthesia Drugs Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2016-2021)
Table 149. Lunan Product
Table 150. Lunan Recent Development
Table 151. General Anesthesia Drugs Market Trends
Table 152. General Anesthesia Drugs Market Drivers
Table 153. General Anesthesia Drugs Market Challenges
Table 154. General Anesthesia Drugs Market Restraints
Table 155. General Anesthesia Drugs Customers List
Table 156. General Anesthesia Drugs Distributors List
Table 157. Research Programs/Design for This Report
Table 158. Key Data Information from Secondary Sources
Table 159. Key Data Information from Primary Sources
List of Figures
Figure 1. General Anesthesia Drugs Product Picture
Figure 2. Global General Anesthesia Drugs Sales Market Share by Type in 2020 & 2027
Figure 3. Propofol Product Picture
Figure 4. Etomidate Product Picture
Figure 5. Midazolam Product Picture
Figure 6. Sevoflurane Product Picture
Figure 7. Isoflurane Product Picture
Figure 8. Others Product Picture
Figure 9. Global General Anesthesia Drugs Sales Market Share by Application in 2020 & 2027
Figure 10. Intravenous Anesthetics
Figure 11. Inhalational Anesthetics
Figure 12. General Anesthesia Drugs Report Years Considered
Figure 13. Global General Anesthesia Drugs Market Size, (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global General Anesthesia Drugs Market Size 2016-2027 (US$ Million)
Figure 15. Global General Anesthesia Drugs Sales 2016-2027 (K L)
Figure 16. Global General Anesthesia Drugs Market Size Market Share by Region: 2021 Versus 2027
Figure 17. Global General Anesthesia Drugs Sales Market Share by Region (2016-2021)
Figure 18. Global General Anesthesia Drugs Sales Market Share by Region in 2020
Figure 19. Global General Anesthesia Drugs Revenue Market Share by Region (2016-2021)
Figure 20. Global General Anesthesia Drugs Revenue Market Share by Region in 2020
Figure 21. Global General Anesthesia Drugs Sales Share by Manufacturer in 2020
Figure 22. The Top 10 and 5 Players Market Share by General Anesthesia Drugs Revenue in 2020
Figure 23. General Anesthesia Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 24. Global General Anesthesia Drugs Sales Market Share by Type (2016-2021)
Figure 25. Global General Anesthesia Drugs Sales Market Share by Type in 2020
Figure 26. Global General Anesthesia Drugs Revenue Market Share by Type (2016-2021)
Figure 27. Global General Anesthesia Drugs Revenue Market Share by Type in 2020
Figure 28. Global General Anesthesia Drugs Sales Market Share by Application (2016-2021)
Figure 29. Global General Anesthesia Drugs Sales Market Share by Application in 2020
Figure 30. Global General Anesthesia Drugs Revenue Market Share by Application (2016-2021)
Figure 31. Global General Anesthesia Drugs Revenue Market Share by Application in 2020
Figure 32. China General Anesthesia Drugs Sales Growth Rate 2016-2027 (K L)
Figure 33. China General Anesthesia Drugs Revenue Growth Rate 2016-2027 (US$ Million)
Figure 34. China General Anesthesia Drugs Market Share in Global Market 2016-2027
Figure 35. China 5 and 10 Largest General Anesthesia Drugs Players Market Share by Revenue in General Anesthesia Drugs in 2020
Figure 36. China General Anesthesia Drugs Revenue Share by Type (2016-2021)
Figure 37. China General Anesthesia Drugs Revenue Growth Rate by Type in 2016 & 2020
Figure 38. China General Anesthesia Drugs Revenue Share by Application (2016-2021)
Figure 39. China General Anesthesia Drugs Revenue Growth Rate by Application in 2016 & 2020
Figure 40. North America General Anesthesia Drugs Sales Growth Rate 2016-2021 (K L)
Figure 41. North America General Anesthesia Drugs Revenue Growth Rate 2016-2021 (US$ Million)
Figure 42. North America General Anesthesia Drugs Sales Market Share by Country in 2020
Figure 43. North America General Anesthesia Drugs Revenue Market Share by Country in 2020
Figure 44. U.S. General Anesthesia Drugs Sales Growth Rate (2016-2021) (K L)
Figure 45. U.S. General Anesthesia Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. Canada General Anesthesia Drugs Sales Growth Rate (2016-2021) (K L)
Figure 47. Canada General Anesthesia Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 48. Europe General Anesthesia Drugs Sales Growth Rate 2016-2021 (K L)
Figure 49. Europe General Anesthesia Drugs Revenue Growth Rate 2016-2021 (US$ Million)
Figure 50. Europe General Anesthesia Drugs Sales Market Share by Country in 2020
Figure 51. Europe General Anesthesia Drugs Revenue Market Share by Country in 2020
Figure 52. Germany General Anesthesia Drugs Sales Growth Rate (2016-2021) (K L)
Figure 53. Germany General Anesthesia Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 54. France General Anesthesia Drugs Sales Growth Rate (2016-2021) (K L)
Figure 55. France General Anesthesia Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 56. U.K. General Anesthesia Drugs Sales Growth Rate (2016-2021) (K L)
Figure 57. U.K. General Anesthesia Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 58. Italy General Anesthesia Drugs Sales Growth Rate (2016-2021) (K L)
Figure 59. Italy General Anesthesia Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 60. Russia General Anesthesia Drugs Sales Growth Rate (2016-2021) (K L)
Figure 61. Russia General Anesthesia Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 62. Asia Pacific General Anesthesia Drugs Sales Growth Rate 2016-2021 (K L)
Figure 63. Asia Pacific General Anesthesia Drugs Revenue Growth Rate 2016-2021 (US$ Million)
Figure 64. Asia Pacific General Anesthesia Drugs Sales Market Share by Region in 2020
Figure 65. Asia Pacific General Anesthesia Drugs Revenue Market Share by Region in 2020
Figure 66. China General Anesthesia Drugs Sales Growth Rate (2016-2021) (K L)
Figure 67. China General Anesthesia Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 68. Japan General Anesthesia Drugs Sales Growth Rate (2016-2021) (K L)
Figure 69. Japan General Anesthesia Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 70. South Korea General Anesthesia Drugs Sales Growth Rate (2016-2021) (K L)
Figure 71. South Korea General Anesthesia Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 72. India General Anesthesia Drugs Sales Growth Rate (2016-2021) (K L)
Figure 73. India General Anesthesia Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 74. Australia General Anesthesia Drugs Sales Growth Rate (2016-2021) (K L)
Figure 75. Australia General Anesthesia Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 76. China Taiwan General Anesthesia Drugs Sales Growth Rate (2016-2021) (K L)
Figure 77. China Taiwan General Anesthesia Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 78. Indonesia General Anesthesia Drugs Sales Growth Rate (2016-2021) (K L)
Figure 79. Indonesia General Anesthesia Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 80. Thailand General Anesthesia Drugs Sales Growth Rate (2016-2021) (K L)
Figure 81. Thailand General Anesthesia Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 82. Malaysia General Anesthesia Drugs Sales Growth Rate (2016-2021) (K L)
Figure 83. Malaysia General Anesthesia Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 84. Latin America General Anesthesia Drugs Sales Growth Rate 2016-2021 (K L)
Figure 85. Latin America General Anesthesia Drugs Revenue Growth Rate 2016-2021 (US$ Million)
Figure 86. Latin America General Anesthesia Drugs Sales Market Share by Country in 2020
Figure 87. Latin America General Anesthesia Drugs Revenue Market Share by Country in 2020
Figure 88. Mexico General Anesthesia Drugs Sales Growth Rate (2016-2021) (K L)
Figure 89. Mexico General Anesthesia Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 90. Brazil General Anesthesia Drugs Sales Growth Rate (2016-2021) (K L)
Figure 91. Brazil General Anesthesia Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 92. Argentina General Anesthesia Drugs Sales Growth Rate (2016-2021) (K L)
Figure 93. Argentina General Anesthesia Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 94. Middle East and Africa General Anesthesia Drugs Sales Growth Rate 2016-2021 (K L)
Figure 95. Middle East and Africa General Anesthesia Drugs Revenue Growth Rate 2016-2021 (US$ Million)
Figure 96. Middle East and Africa General Anesthesia Drugs Sales Market Share by Country in 2020
Figure 97. Middle East and Africa General Anesthesia Drugs Revenue Market Share by Country in 2020
Figure 98. Turkey General Anesthesia Drugs Sales Growth Rate (2016-2021) (K L)
Figure 99. Turkey General Anesthesia Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 100. Saudi Arabia General Anesthesia Drugs Sales Growth Rate (2016-2021) (K L)
Figure 101. Saudi Arabia General Anesthesia Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 102. UAE General Anesthesia Drugs Sales Growth Rate (2016-2021) (K L)
Figure 103. UAE General Anesthesia Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 104. General Anesthesia Drugs Value Chain
Figure 105. Channels of Distribution
Figure 106. Distributors Profiles
Figure 107. Bottom-up and Top-down Approaches for This Report
Figure 108. Data Triangulation
Figure 109. Key Executives Interviewed

---